March 23, 2021

Keytruda Receives New Esophageal Cancer Indication

Read More
March 22, 2021

Zegalogue Approved to Treat Severe Hypoglycemia

Read More
March 19, 2021

Ponvory Approved to Treat Multiple Sclerosis

Read More
March 18, 2021

Arcalyst Receives New Indication for Inflammation of the Pericardium

Read More
March 18, 2021

FDA Updates Fact Sheets for Monoclonal Antibodies Used to Treat COVID-19

Read More
March 15, 2021

Kimyrsa Approved to Treat Bacterial Skin and Skin Structure Infections

Read More
March 15, 2021

Fabrazyme Receives Expanded Indication for Fabry Disease

Read More
March 11, 2021

Sagent Pharmaceuticals Recalls Phenylephrine HCl Injection

Read More
March 10, 2021

Fotivda Approved to Treat Renal Cell Carcinoma

Read More
March 9, 2021

Bryant Ranch Prepack Recalls Spironolactone Tablets

Read More
March 8, 2021

FDA Grants Tentative Approval for Symbicort Generic

Read More
March 8, 2021

Tecentriq No Longer Indicated for Prior-Platinum Treated Metastatic Urothelial Carcinoma

Read More